Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials
Table 1
Study Designs, Demographic and Baseline Characteristics.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Study Designs, Demographic and Baseline Characteristics.